进一步推动上合卫健领域交流合作 中国—上合组织代谢性疾病合作中心在瑞金医院成立

Core Insights - The establishment of the China-Shanghai Cooperation Organization Metabolic Disease Cooperation Center is a significant step in addressing metabolic diseases among member countries, reflecting the implementation of directives from Chinese leadership [1][2] - The center aims to enhance collaboration among SCO member states in tackling metabolic diseases, which are a leading cause of death in the region, accounting for over 70% of all deaths [2] Group 1: Center Establishment and Objectives - The center is the first national-level SCO specialized cooperation platform established in Shanghai, focusing on the systematic governance of metabolic diseases [1] - It will undertake tasks such as medical assistance, training, technology sharing, and industrial technology exchange, with a goal to train 2,000 experts in metabolic disease prevention and control within three years [1] - The center plans to share 500 medical technologies across the region and propose the establishment of the SCO Metabolic Forum to further promote health cooperation [1] Group 2: Context and Importance - Approximately 50% of metabolic disease patients globally are from SCO-related countries, highlighting the urgent need for targeted health initiatives in this region [2] - Shanghai, as the birthplace of the SCO, is a hub for medical resources and activities, with a distinctive health management system for metabolic diseases that has been established [2] - The city aims to integrate the center into key support projects, enhancing policy support, resource coordination, and service provision to become a central hub for medical technology exchange and talent development [2]